Pharmaceutical product sales scale of 3 terminals and 6 markets in China in 2016
|
2016年我国药品终端市场销售额实现¥14975亿 |
Chinese pharmaceutical product terminal markets achieved RMB 1.4975 trillion sales in 2016 |
|
同比增长8.3% |
growing by 8.3% year on year |
|
图1 2010-2016年全国药品终端市场药品销售额及增长(单位:亿元) |
Fig. 1 Pharmaceutical product sales and growth of Chinese pharmaceutical product terminal markets in 2010-2016 (in RMB 100 million) |
From the perspective of the sales distribution of the three terminals achieving pharmaceutical product sale:
The public hospital terminal had the largest market share, accounting for 68.4% in 2016
The retail pharmacy terminal had the market share of 22.5% in 2016
The market share of the public grass-roots medical terminal has grown in recent years, and that in 2016 accounted for 9.1%

|
第一终端:公立医院终端 |
1st terminal: Public hospital terminal |
|
第二终端:零售药店终端 |
2nd terminal: Retail pharmacy terminal |
|
第三终端:公立基层医疗终端 |
3rd terminal: Public grass-roots medical terminal |
|
图2 2010-2016年全国药品市场三大终端销售额分布 |
Fig. 2 Sales distribution of three terminals in Chinese pharmaceutical product market in 2010-2016 |

|
第一终端:公立医院终端 |
1st terminal: Public hospital terminal |
|
公立医院终端销售额保持增长势态,但增速持续放缓,2016年销售额达到¥10240亿 |
Sales of the public hospital terminal maintained the growth situation, but the growth continued to slow down, with 2016 sales reaching RMB 1.0240 trillion |
|
同比增长7.6% |
growing by 7.6% year on year |
|
图3 2010-2016年全国公立医院终端药品销售额及增长(单位:亿元) |
Fig. 3 Pharmaceutical product sales and growth of Chinese public hospital terminal in 2010-2016 (in RMB 100 million) |

|
第一终端:城市公立医院市场 |
1st terminal: City public hospital market |
|
公立医院终端包含城市公立医院及县级公立医院两大市场。2015[a1] 年城市公立医院市场的销售额实现¥7675亿 |
The public hospital terminal includes city public hospital and county public hospital markets. The city hospital market achieved sales of RMB 767.5 billion in 2016 |
|
同比增长6.1% |
growing by 6.1% year on year ...Read More
Related News
Made-in-China New Drugs: Breaking Through the RMB 4-Billion Battlefield
lezhi September 5, 2025
FDA Approves Drug to Treat Duchenne Muscular Dystrophy
americanpharmaceuticalreview February 13, 2017
Owlstone Medical commences 1,400 patient clinical trial for early detection of colorectal cancer
pharmaasia February 13, 2017 You may like
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Most popular
Apeloa Pharmaceutical releases first ESG
PharmaSources
May 12, 2025
Basic Concepts and Latest Trends in Radiation Biology: Emerging Insights and Future Directions
Sadia Ajmal
Sep 18, 2025
Methodology Validation in Chinese Pharmacopoeia 2025: How to Report Accuracy and Precision
Xing Xing
Sep 12, 2025
Digitalization in Procurement: From AI Forecasting to Blockchain Traceability
Saher Haider
Sep 19, 2025
|









(All Rights Reserved)